Skip to main content

Carolyn Compton, Caren Mason

HealthTell said this week that Carolyn Compton and Caren Mason have joined the company's board of directors.

Compton is chief medical officer of the National Biomarkers Development Alliance at Arizona State Universitywhere she is also a professor of life sciences.

Mason was formerly CEO of Verinata Health, which was acquired by Illumina in 2013. Before that she was CEO of Quidel.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.